Patent Assignment
Reel/Frame 050180/0309
General Conveyance and Assumption Agreement
Recorded: 2019-08-27
Pages: 5
Assignor
RVX THERAPEUTICS INC.
Executed: 2014-05-01
Assignee
ZENITH EPIGENETICS CORP.
300,4820 RICHARD ROAD SW, CALGARY, AB, T3E 6L1, CANADA
Covered Property
(1)
Novel Quinazolinones as Bromodomain Inhibitors
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 27, 2019
From: QUINN, JOHN FREDERICK; KHLEBNIKOV, VLADIMIR
To: RVX THERAPEUTICS INC.
Reel/Frame 050180/0219 →
Change of Name
Aug 27, 2019
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 050180/0326 →
Assignment of Assignor's Interest
Aug 27, 2019
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 050180/0339 →